Phase 1 Clinical Trial Met All Primary and Secondary Endpoints and Demonstrated Positive Safety, Pharmacokinetics, and ...

Mucosal surfaces serve as critical battlegrounds where the immune system must balance tolerance to commensal organisms with rapid defense against pathogens.

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...

New research identifies a specific monocyte gene signature that predicts mortality in IPF, offering potential targets ...

SIGLEC Phase 2b data support AVD-104 as a potential therapy to reduce GA lesion growth, preserve and improve visual acuity, and reduce conversion to neovascular AMD across all GA lesion types at 1 ...

In an article published in Mucosal Immunology, scientists show that IgA antibodies present in mucous membranes play a key ...

For years, orange juice has been sold as a simple source of vitamin C, but new human data suggest that a morning glass may be ...

Fructose can dramatically increase the sensitivity of immune cells to bacterial toxins, researchers at the University of ...

Overall, this study highlights a hidden danger in common dietary sugars: fructose not only affects metabolism but actively ...

Researchers found that fructose can prime immune cells to overreact to bacterial toxins. In healthy adults, fructose-sweetened drinks increased receptors that trigger inflammation. This heightened ...